- Use of a temporary intraoperative mesentericoportal shunt for pancreatic resection for locally advanced pancreatic cancer with portal vein occlusion and portal hypertensionPhilippe Bachellier
Hepato Pancreato Biliary Surgery and Liver Transplantation, Pôle des Pathologies Digestives, Hépatiques et de la Transplantation, Hôpital de Hautepierre Hôpitaux Universitaires de Strasbourg, Universite de Strasbourg, Strasbourg, France Electronic address
Surgery 155:449-56. 2014....
- Is the need for an arterial resection a contraindication to pancreatic resection for locally advanced pancreatic adenocarcinoma? A case-matched controlled studyPhilippe Bachellier
Centre de Chirurgie Viscerale et de Transplantation, Hopitaux Universitaires de Strasbourg, CHU Hautepierre, Strasbourg Cedex, France
J Surg Oncol 103:75-84. 2011..Arterial resection (AR) has traditionally been considered as a contraindication to pancreatic resection for locally advanced pancreatic adenocarcinoma. The objective was to evaluate if pancreatic resection with AR was worthwhile...
- Laparoscopic treatment of biliary peritonitis following nonoperative management of blunt liver traumaEttore Marzano
Pôle des Pathologies Digestives, Hépatiques et de la Transplantation, Hôpital de Hautepierre Universitaires de Strasbourg, Avenue Moliere, 67098 Strasbourg Cedex, France
World J Emerg Surg 5:26. 2010..However, it is associated with several in-hospital complications. In selected cases laparoscopy could be proposed as diagnostic and therapeutic means...
- Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)Stefan Heinrich
Department of General and Abdominal Surgery, University Hospital of Mainz, Langenbeck Strasse 1, 55118 Mainz, Germany
BMC Cancer 11:346. 2011..Moreover, neoadjuvant chemotherapy improves the nutritional status of patients with pancreatic cancer. This multicenter phase III trial (NEOPAC) has been designed to explore the efficacy of neoadjuvant chemotherapy...